메뉴 건너뛰기




Volumn 32, Issue 21, 2014, Pages 2507-2517

Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial

Author keywords

Antibodies; High dose vaccine; Intradermal; Older adults; Safety; Trivalent influenza vaccine

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE;

EID: 84898416764     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.074     Document Type: Article
Times cited : (74)

References (40)
  • 1
    • 84862776821 scopus 로고    scopus 로고
    • The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines
    • McElhaney J.E., Zhou X., Talbot H.K., Soethout E., Bleackley R.C., Granville D.J., et al. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 2012, 30(12):2060-2067.
    • (2012) Vaccine , vol.30 , Issue.12 , pp. 2060-2067
    • McElhaney, J.E.1    Zhou, X.2    Talbot, H.K.3    Soethout, E.4    Bleackley, R.C.5    Granville, D.J.6
  • 2
    • 0037425564 scopus 로고    scopus 로고
    • Mortality associated with influenza and respiratory syncytial virus in the United States
    • Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186.
    • (2003) JAMA , vol.289 , Issue.2 , pp. 179-186
    • Thompson, W.W.1    Shay, D.K.2    Weintraub, E.3    Brammer, L.4    Cox, N.5    Anderson, L.J.6
  • 3
    • 32044453088 scopus 로고    scopus 로고
    • Antibody response to influenza vaccination in the elderly: a quantitative review
    • Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24(8):1159-1169.
    • (2006) Vaccine , vol.24 , Issue.8 , pp. 1159-1169
    • Goodwin, K.1    Viboud, C.2    Simonsen, L.3
  • 4
    • 84861957178 scopus 로고    scopus 로고
    • Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence
    • Lang P.O., Mendes A., Socquet J., Assir N., Govind S., Aspinall R. Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging 2012, 7:55-64.
    • (2012) Clin Interv Aging , vol.7 , pp. 55-64
    • Lang, P.O.1    Mendes, A.2    Socquet, J.3    Assir, N.4    Govind, S.5    Aspinall, R.6
  • 5
    • 80455126055 scopus 로고    scopus 로고
    • Improving immunogenicity and effectiveness of influenza vaccine in older adults
    • Cao W., Kim J.H., Chirkova T., Reber A.J., Biber R., Shay D.K., et al. Improving immunogenicity and effectiveness of influenza vaccine in older adults. Expert Rev Vaccines 2011, 10(11):1529-1537.
    • (2011) Expert Rev Vaccines , vol.10 , Issue.11 , pp. 1529-1537
    • Cao, W.1    Kim, J.H.2    Chirkova, T.3    Reber, A.J.4    Biber, R.5    Shay, D.K.6
  • 6
    • 50949128086 scopus 로고    scopus 로고
    • Better influenza vaccines for older people: what will it take?
    • McElhaney J.E., Dutz J.P. Better influenza vaccines for older people: what will it take?. J Infect Dis 2008, 198(5):632-634.
    • (2008) J Infect Dis , vol.198 , Issue.5 , pp. 632-634
    • McElhaney, J.E.1    Dutz, J.P.2
  • 7
    • 44749091856 scopus 로고    scopus 로고
    • Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
    • Lambert P.H., Laurent P.E. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?. Vaccine 2008, 26(26):3197-3208.
    • (2008) Vaccine , vol.26 , Issue.26 , pp. 3197-3208
    • Lambert, P.H.1    Laurent, P.E.2
  • 8
    • 80052916947 scopus 로고    scopus 로고
    • Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine
    • Durando P., Iudici R., Alicino C., Alberti M., de Florentis D., Ansaldi F., et al. Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. Hum Vaccin 2011, (7 Suppl):29-40.
    • (2011) Hum Vaccin , Issue.7 SUPPL. , pp. 29-40
    • Durando, P.1    Iudici, R.2    Alicino, C.3    Alberti, M.4    de Florentis, D.5    Ansaldi, F.6
  • 9
    • 84859261780 scopus 로고    scopus 로고
    • Transcutaneous and intradermal vaccination
    • Combadiere B., Liard C. Transcutaneous and intradermal vaccination. Hum Vaccin 2011, 7(8):811-827.
    • (2011) Hum Vaccin , vol.7 , Issue.8 , pp. 811-827
    • Combadiere, B.1    Liard, C.2
  • 10
    • 18244386226 scopus 로고    scopus 로고
    • Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination
    • Chen Q., Jackson H., Shackleton M., Parente P., Hopkins W., Sturrock S., et al. Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination. Cancer Immun 2005, 5:5.
    • (2005) Cancer Immun , vol.5 , pp. 5
    • Chen, Q.1    Jackson, H.2    Shackleton, M.3    Parente, P.4    Hopkins, W.5    Sturrock, S.6
  • 11
    • 53849147254 scopus 로고    scopus 로고
    • Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice
    • Nicolas J.F., Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008, 7(8):1201-1214.
    • (2008) Expert Rev Vaccines , vol.7 , Issue.8 , pp. 1201-1214
    • Nicolas, J.F.1    Guy, B.2
  • 12
    • 79851480211 scopus 로고    scopus 로고
    • Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement
    • Ansaldi F., Durando P., Icardi G. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opin Biol Ther 2011, 11(3):415-427.
    • (2011) Expert Opin Biol Ther , vol.11 , Issue.3 , pp. 415-427
    • Ansaldi, F.1    Durando, P.2    Icardi, G.3
  • 13
    • 84876079444 scopus 로고    scopus 로고
    • Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18 to 64 years of age
    • Gorse G.J., Falsey A.R., Fling J.A., Poling T.L., Strout C.B., Tsang P.H. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18 to 64 years of age. Vaccine 2013, 31:2358-2365.
    • (2013) Vaccine , vol.31 , pp. 2358-2365
    • Gorse, G.J.1    Falsey, A.R.2    Fling, J.A.3    Poling, T.L.4    Strout, C.B.5    Tsang, P.H.6
  • 14
    • 70649093804 scopus 로고    scopus 로고
    • Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study
    • Arnou R., Icardi G., De Decker M., Ambrozaitis A., Kazek M.P., Weber F., et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009, 27(52):7304-7312.
    • (2009) Vaccine , vol.27 , Issue.52 , pp. 7304-7312
    • Arnou, R.1    Icardi, G.2    De Decker, M.3    Ambrozaitis, A.4    Kazek, M.P.5    Weber, F.6
  • 15
    • 50949102312 scopus 로고    scopus 로고
    • Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial
    • Holland D., Booy R., De Looze F., Eizenberg P., McDonald J., Karrasch J., et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008, 198(5):650-658.
    • (2008) J Infect Dis , vol.198 , Issue.5 , pp. 650-658
    • Holland, D.1    Booy, R.2    De Looze, F.3    Eizenberg, P.4    McDonald, J.5    Karrasch, J.6
  • 16
    • 77955701149 scopus 로고    scopus 로고
    • Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010
    • RR-8
    • Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59(RR-8):1-62.
    • (2010) MMWR Recomm Rep , vol.59 , pp. 1-62
    • Fiore, A.E.1    Uyeki, T.M.2    Broder, K.3    Finelli, L.4    Euler, G.L.5    Singleton, J.A.6
  • 17
    • 77951912690 scopus 로고    scopus 로고
    • Licensure of a high-dose inactivated influenza vaccine for persons aged > or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention Licensure of a high-dose inactivated influenza vaccine for persons aged > or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010. MMWR Morb Mortal Wkly Rep 2010, 59(16):485-486.
    • (2010) MMWR Morb Mortal Wkly Rep , vol.59 , Issue.16 , pp. 485-486
  • 18
    • 67650665332 scopus 로고    scopus 로고
    • Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older
    • Falsey A.R., Treanor J.J., Tornieporth N., Capellan J., Gorse G.J. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009, 200(2):172-180.
    • (2009) J Infect Dis , vol.200 , Issue.2 , pp. 172-180
    • Falsey, A.R.1    Treanor, J.J.2    Tornieporth, N.3    Capellan, J.4    Gorse, G.J.5
  • 19
    • 0002733214 scopus 로고
    • U.S. Department of Health, Education and Welfare, Atlanta, Georgia, D.F. Palmer, W.R. Dowdle, M.T. Coleman, G.C. Shild (Eds.)
    • Advanced laboratory techniques for influenza diagnosis. Procedural guide, immunology series no. 6 1975, 25-62. U.S. Department of Health, Education and Welfare, Atlanta, Georgia. D.F. Palmer, W.R. Dowdle, M.T. Coleman, G.C. Shild (Eds.).
    • (1975) Advanced laboratory techniques for influenza diagnosis. Procedural guide, immunology series no. 6 , pp. 25-62
  • 20
    • 85081456443 scopus 로고    scopus 로고
    • International Conference on Harmonisation. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting (ICH E2A). 1995 [cited 2012 May 23; Available from:.
    • International Conference on Harmonisation. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting (ICH E2A). 1995 [cited 2012 May 23; Available from:. http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html.
  • 21
    • 0032716199 scopus 로고    scopus 로고
    • A descriptive study of the use of visual analogue scales and verbal rating scales for the assessment of postoperative pain in orthopedic patients
    • Briggs M., Closs J.S. A descriptive study of the use of visual analogue scales and verbal rating scales for the assessment of postoperative pain in orthopedic patients. J Pain Symptom Manage 1999, 18(6):438-446.
    • (1999) J Pain Symptom Manage , vol.18 , Issue.6 , pp. 438-446
    • Briggs, M.1    Closs, J.S.2
  • 24
    • 77149133721 scopus 로고    scopus 로고
    • A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
    • Cate T.R., Rayford Y., Nino D., Winokur P., Brady R., Belshe R., et al. A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine 2010, 28(9):2076-2079.
    • (2010) Vaccine , vol.28 , Issue.9 , pp. 2076-2079
    • Cate, T.R.1    Rayford, Y.2    Nino, D.3    Winokur, P.4    Brady, R.5    Belshe, R.6
  • 25
    • 35048838041 scopus 로고    scopus 로고
    • Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
    • Couch R.B., Winokur P., Brady R., Belshe R., Chen W.H., Cate T.R., et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 2007, 25(44):7656-7663.
    • (2007) Vaccine , vol.25 , Issue.44 , pp. 7656-7663
    • Couch, R.B.1    Winokur, P.2    Brady, R.3    Belshe, R.4    Chen, W.H.5    Cate, T.R.6
  • 26
    • 33646808066 scopus 로고    scopus 로고
    • Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons
    • Keitel W.A., Atmar R.L., Cate T.R., Petersen N.J., Greenberg S.B., Ruben F., et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 2006, 166(10):1121-1127.
    • (2006) Arch Intern Med , vol.166 , Issue.10 , pp. 1121-1127
    • Keitel, W.A.1    Atmar, R.L.2    Cate, T.R.3    Petersen, N.J.4    Greenberg, S.B.5    Ruben, F.6
  • 27
    • 79953199370 scopus 로고    scopus 로고
    • Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine
    • Chen W.H., Cross A.S., Edelman R., Sztein M.B., Blackwelder W.C., Pasetti M.F. Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. Vaccine 2011, 29(16):2865-2873.
    • (2011) Vaccine , vol.29 , Issue.16 , pp. 2865-2873
    • Chen, W.H.1    Cross, A.S.2    Edelman, R.3    Sztein, M.B.4    Blackwelder, W.C.5    Pasetti, M.F.6
  • 28
    • 85081456256 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials.
    • U.S. Food and Drug Administration Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials. 2007. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm074775.htm.
    • (2007)
  • 29
    • 84863719193 scopus 로고    scopus 로고
    • Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: an on-field national study
    • Durando P., Alicino C., Alberti M., Sticchi L., Turello V., Marensi L., et al. Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: an on-field national study. Adv Ther 2012, 29(4):312-326.
    • (2012) Adv Ther , vol.29 , Issue.4 , pp. 312-326
    • Durando, P.1    Alicino, C.2    Alberti, M.3    Sticchi, L.4    Turello, V.5    Marensi, L.6
  • 31
    • 84857906660 scopus 로고    scopus 로고
    • Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey
    • Prymula R., Usluer G., Altinel S., Sichova R., Weber F. Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey. Adv Ther 2012, 29(1):41-52.
    • (2012) Adv Ther , vol.29 , Issue.1 , pp. 41-52
    • Prymula, R.1    Usluer, G.2    Altinel, S.3    Sichova, R.4    Weber, F.5
  • 33
    • 84859002756 scopus 로고    scopus 로고
    • ® 15 μg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses
    • ® 15 μg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses. Vaccine 2012, 30(18):2908-2913.
    • (2012) Vaccine , vol.30 , Issue.18 , pp. 2908-2913
    • Ansaldi, F.1    Canepa, P.2    Ceravolo, A.3    Valle, L.4    de Florentiis, D.5    Oomen, R.6
  • 34
    • 84860209610 scopus 로고    scopus 로고
    • Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection
    • Koutsonanos D.G., Vassilieva E.V., Stavropoulou A., Zarnitsyn V.G., Esser E.S., Taherbhai M.T., et al. Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep 2012, 2:357.
    • (2012) Sci Rep , vol.2 , pp. 357
    • Koutsonanos, D.G.1    Vassilieva, E.V.2    Stavropoulou, A.3    Zarnitsyn, V.G.4    Esser, E.S.5    Taherbhai, M.T.6
  • 36
    • 55649101168 scopus 로고    scopus 로고
    • Micro-scale devices for transdermal drug delivery
    • Arora A., Prausnitz M.R., Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008, 364(2):227-236.
    • (2008) Int J Pharm , vol.364 , Issue.2 , pp. 227-236
    • Arora, A.1    Prausnitz, M.R.2    Mitragotri, S.3
  • 37
    • 77956293519 scopus 로고    scopus 로고
    • Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial
    • Combadiere B., Vogt A., Mahe B., Costagliola D., Hadam S., Bonduelle O., et al. Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One 2010, 5(5):e10818.
    • (2010) PLoS One , vol.5 , Issue.5
    • Combadiere, B.1    Vogt, A.2    Mahe, B.3    Costagliola, D.4    Hadam, S.5    Bonduelle, O.6
  • 38
    • 78651228601 scopus 로고    scopus 로고
    • Microneedles in clinical practice-an exploratory study into the opinions of healthcare professionals and the public
    • Birchall J.C., Clemo R., Anstey A., John D.N. Microneedles in clinical practice-an exploratory study into the opinions of healthcare professionals and the public. Pharm Res 2011, 28(1):95-106.
    • (2011) Pharm Res , vol.28 , Issue.1 , pp. 95-106
    • Birchall, J.C.1    Clemo, R.2    Anstey, A.3    John, D.N.4
  • 40
    • 0021186924 scopus 로고
    • A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection
    • Masurel N., Laufer J. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection. J Hyg (Lond) 1984, 92(3):263-276.
    • (1984) J Hyg (Lond) , vol.92 , Issue.3 , pp. 263-276
    • Masurel, N.1    Laufer, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.